racecadotril also known acetorphan antidiarrheal medication acts peripheral enkephalinase unlike opioid medications used treat diarrhea reduce intestinal motility racecadotril antisecretory effect reduces secretion water electrolytes available france first introduced european countries including germany italy united kingdom spain portugal poland finland russia czech republic well south america south east asian countries including china india thailand united states sold tradename hidrasec among thiorphan active metabolite racecadotril exerts bulk inhibitory actions racecadotril used treatment acute diarrhea children adults better tolerability loperamide causes less constipation several guidelines recommended racecadotril use addition oral rehydration treatment children acute racecadotril contraindications apart known hypersensitivity insufficient data therapy chronic diarrhea patients renal hepatic failure children three months additional contraindications childrens formulation hereditary fructose intolerance glucosegalactose malabsorption saccharase deficiency contains common adverse effect headache occurs rashes occur fewer patients described skin reactions include itching urticaria angioedema erythema multiforme erythema cases overdose known adults tolerated therapeutic doses without ill interactions humans described combining racecadotril ace inhibitor theoretically increase risk racecadotril main metabolites neither inhibit induce liver enzymes also induce ugt means racecadotril low potential pharmacokinetic interactions enkephalins peptides produced body act opioid receptors preference δ activation δ receptors inhibits enzyme adenylyl cyclase decreasing intracellular levels messenger molecule active metabolite racecadotril thiorphan inhibits enkephalinase enzymes intestinal epithelium nm protecting enkephalins broken enzymes racecadotril much less potent reduces diarrhea related hypersecretion small intestine without influencing basal secretion racecadotril also influence time substances bacteria virus particles stay racecadotril rapidly absorbed oral administration reaches cmax within minutes food delays cmax minutes affect overall bioavailability racecadotril rapidly effectively metabolized moderately active sacetylthiorphan main active metabolite thiorphan bound blood plasma proteins therapeutic doses racecadotril pass barrier inhibition enkephalinases starts minutes administration reaches maximum inhibition therapeutic dose two hours administration lasts eight hours elimination halflife measured enkephalinase inhibition three thiorphan metabolized inactive metabolites methyl thioether methyl sulfoxide active inactive metabolites excreted mostly via kidney lesser extent via feces france portugal spain sold tiorfan italy tiorfix india available redotril httpsenwikipediaorgwikiracecadotril